Home Wanjie Medical Raises ¥100M Strategic Investment from Elite Capital

Wanjie Medical Raises ¥100M Strategic Investment from Elite Capital

CST Updated May 12, 2021 19:16

(VCBeat) Apr. 26, 2021-- Recently, Beijing Wanjie Medical Device Co., Ltd. ("Wanjie Medical"), a leading company of sports medicine in China, received a strategic investment of more than RMB 100 million from Elite Capital, which is another investment of Elite Capital in the field of sports medicine in China. WinX Capital serves as the exclusive financial consultant.


At present, the sports medicine market in China is facing an unprecedented opportunity. Although the domestic enterprises are in the early stage of development, they have already had the ability to compete with the foreign counterparts that occupy the dominant position in the market technologically. The tide of imported product substitution is coming.


In this track, Wanjie Medical is engaged in the research and development, production and sales of high-value consumables in the field of sports medicine and orthopedic implants. It is a national high-tech enterprise and the only company that enters the field of orthopedic repair from sports medicine in China. The company mainly provides orthopedic surgical instruments and supplies for hospitals at all levels at home and abroad. The fund raised this time will be mainly used for product R&D in sports medicine and orthopedic surgery and accelerate product commercialization.


As the vice president unit of China Sports Medicine Innovation Alliance, Wanjie Medical has an innovative R&D team led by well-known clinical experts and a master and doctoral R&D team of " optimal youth talents". It has gathered a large number of R&D professionals in the field of polymer biological materials, tissue engineering, machinery and automation. It has formed an interdisciplinary team covering product design, material, production, medicine, legal affairs and marketing.


At the same time, in April this year, Wanjie Medical successfully obtained two class III medical device registration certificates issued by the National Medical Products Administration (NMPA). The certificates relate to two core products in the field of sports medicine: the screw for ligament fixation and the suture anchor.


>>>>

About Elite Capital


Elite Capital was founded in 2009, "focusing on being the partner behind the founder". Elite Capital aims to build a private equity investment institution with the characteristics of deep exploration in the industry and integration of the upstream and downstream of the industrial chain. It invests in the biotech, medical cosmetology and medical device industries through long-term value investment.